WebRecognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression WebApr 4, 2024 · Stem cell therapy, explicitly mesenchymal stem cells (MSCs), has gained significant attention recently as a potential treatment for autoimmune diseases, including scleroderma. MSCs have unique properties that make them particularly promising for treating these conditions. What are Stem Cells?
Scleroderma: Preventing Complications and Reducing Morbidity
WebOct 20, 2024 · A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma. The safety and scientific validity of this study is … WebMay 23, 2024 · Systemic sclerosis (SSc) is a rare connective-tissue disease characterized by autoimmune pathogenesis, alterations to the vascular system, and fibrosis of the skin and internal organs. 1 It is estimated that about 30% of SSc patients develop digital ulcers (DUs) yearly and up to 50% of subjects develop this complication during the natural course … ontrack release tracking
Scleroderma - Symptoms and causes - Mayo Clinic
WebMay 25, 2024 · Treatment can help control the symptoms and limit damage. Your doctor may recommend medications, including: Anti-inflammatory medications to manage pain … WebFeb 1, 2007 · Inclusion criteria for the study included an unambiguous diagnosis of systemic scleroderma, typically made by a Mayo Clinic rheumatologist or dermatologist, and treatment with radiation (external beam radiotherapy [EBRT] or brachytherapy or both) at Mayo Clinic Rochester. WebMar 17, 2024 · The hypothesis: B-cell depletion with rituximab would improve lung function in patients with scleroderma-associated PAH. Patients enrolled in the study were … on track report